Editorial: Antimicrobial resistance and therapy in critically ill patients, volume II - Takeaways - MDSpire

Editorial: Antimicrobial resistance and therapy in critically ill patients, volume II

  • By

  • Xiao-Hong Zhou

  • Zhi-Tao Yang

  • Shun-Jin Zhao

  • Qi Li

  • Jian-Cang Zhou

  • June 25, 2026

  • 0 min

Share

  • 1

    Multidrug-resistant pathogens pose significant challenges in critically ill patients, contributing to increased mortality and treatment failure.

  • 2

    Research includes studies on last-line antibiotics and novel strategies for managing infections caused by multidrug-resistant Gram-negative bacteria.

  • 3

    Precision therapeutic drug monitoring has advanced, showing improved accuracy in dosing for critically ill patients compared to traditional methods.

  • 4

    Postoperative pulmonary complications are common after emergency laparotomy, with specific preoperative factors linked to higher mortality.

  • 5

    Innovative non-antimicrobial infection control methods, such as cold atmospheric-pressure plasma, show promise in inactivating multidrug-resistant pathogens.

Original Source(s)

Editorial: Antimicrobial resistance and therapy in critically ill patients, volume II

  • by Xiao-Hong Zhou, Zhi-Tao Yang, Shun-Jin Zhao, Qi Li, Jian-Cang Zhou

  • June 25, 2026

Related Content

Age and hypoalbuminemia independently predict pulmonary consolidation in children with 23S rRNA A2063G-mutant Mycoplasma pneumoniae pneumonia: a retrospective single-center study

Does Sedative Choice Shape Later Cognition?

Researchers examined long-term cognitive outcomes among children who received ICU sedation for acute respiratory failure.

Adjuvant-driven epitope hierarchy correlates with the protective efficacy of FimA vaccine against Klebsiella pneumoniae